With the enormous response from the previous annual SciTech conferences, We are Glad to inform you 2nd International Conference on HIV-AIDS, STD's & STI's. (HIV AIDS 2020) which is slated at March 16 - 17, 2020. Orlando, Florida, USA. HIV AIDS 2020 brings together the Global leaders in HIV, Infectious and relevant fields to present their research at this exclusive scientific program. The HIV AIDS Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Infectious and Immunology. HIV AIDS 2020 Scientific Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.
(99% of participants would recommend the conference to a colleague).
Details of HIV AIDS Conference 2020 in Orlando, USA:
| 2nd International Conference On
HIV-AIDS, STD's & STI's
|Orlando, USA||March 16-17, 2020|
The HIV-AIDS 2020 includes 40+ plenary lectures, dedicated poster sessions and interactive elements. The medium-large size of the conference makes it an excellent forum to share new data, and to network with colleagues and speakers.
HIV-AIDS Diagnostics Market - Growth, Future Prospects, and Competitive Analysis, 2018 - 2025, the global HIV-AIDS diagnostics market was valued at US$ 3,791.2 million in 2016, and is expected to reach US$ 8.718.8 million by 2025, expanding at a CAGR of 9.4% from 2017 to 2025. According to world health organization (WHO), it is a main global public health issue. In 2014, 1.2 million people died with HIV related infections across the globe and approximately 36.8 million people are currently suffering from HIV. As a result, the global HIV diagnosis and treatment market is rapidly growing, and continuously working on trials for the proper diagnosis followed by treatment. The market for HIV diagnosis and treatment market is growing at the pace, and also the increasing occurrence of HIV-AIDS infection globally boosting is the market, also government taking initiatives diagnosis and treatment and increasing in blood donations and blood transfusions and increasing awareness about HIV-AIDS. One of the major reason for the increase in the number of HIV infection across the globe, includes, changing lifestyle, injection drug usage, and lack of awareness and unprotected sex in some region. A prime factor driving the market for HIV diagnosis and treatment market is government and Non-governmental organizations (NGOs) efforts to initiate against HIV-AIDS.
Human immunodeficiency virus (HIV) is one of the most infectious diseases with around 36.7 million people suffering by the end of 2015, according to The Joint United Nations Programme on HIV-AIDS (UNAIDS). Global HIV Drug Market was valued at $20,448 million in 2015 and is expected to garner $26,458 million by 2022. In 2018 the global HIV drugs market exceeded a value of US$ 17 Billion. Looking forward, the market value is expected to reach nearly US$ 21 Billion by 2022, expanding at a CAGR of more than 3% during 2018-2025.
Highlights HIV-AIDS 2020 conference
- Learn about the latest research in your field
- Grow as a researcher and presenter
- Obtain feedback on your research
- Meet and get to know your peers
- Gain visibility in your field
- Share your research findings with others in your field
- Regroup and rethink
- Stay on top of trends and topics
- Promote Creativity & Innovation in business field
- 150+ Participation – Industry- Academia & Companies
- 15+ Keynote Speakers
- 40+ Plenary Speakers
- 5+ Exhibitors
- One to One interactions Sessions based on attendee proposals
- B2B Meetings
Who should attend?
We welcome all Individuals representing academia, public health researchers and practitioners, HIV researchers, immunologists & virologist, physicians, nurses/nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to STD AIDS research and business, transnational and clinical scientists (including postdocs and trainees), who are interested in tackling pressing cancer-relevant questions, and who want to hear the latest developments in therapies targeting cancer, oncology and immune cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators.
First round of Abstract submission deadline December 10, 2019
Second round of Abstract submission deadline January 15, 2020
Final round of Abstract submission deadline February 20, 2020
Acceptance notification: within 24 to 48 hours after submission of abstract
Events Starts in